2m 2m 2m 2m 2m 2m 2m
OCUGEN (OCGN)
NASDAQ
$1.41-$0.004 (-0.28%)
Price as of Jul 14, 2026 4:44 AM EDT- $497.6MMarket Cap
- 27.03%1-Year Change
- BiotechnologyIndustry
OCUGEN (OCGN)
$1.41-$0.004 (-0.28%)
OCGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.41 | ||
Change | -$0.06 (-4.08%) | ||
Open | $1.44 | ||
High | $1.47 | ||
Low | $1.40 | ||
Previous Close | $1.47 | ||
Volume | 5,548,395 | ||
30-Day Average Volume | 10,590,118 | ||
1-Week Change | -5.37% | ||
1-Month Change | 16.53% | ||
1-Year Change | 27.03% | ||
3-Year Change | 138.10% | ||
5-Year Change | -79.02% | ||
Fundamentals | |||
Shares Outstanding | 338.5M | ||
Total Assets | $56.9M | ||
Market Cap | $497.6M | ||
Enterprise Value | $495.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$19.2M | ||
Free Cash Flow | -$21.8M | ||
EBIT | -$17.9M | ||
EBITDA | -$17.3M | ||
Net Working Capital | $17.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 323 | ||
P/B | 86 | ||
P/E | -25 | ||
PEG | 4 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue